These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2225829)

  • 1. Membranes for blood purification: state of the art and new developments.
    Strathmann H; Göhl H
    Contrib Nephrol; 1990; 78():119-40; discussion 140-1. PubMed ID: 2225829
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
    Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
    Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial 1972: Dialysers and blood loss in regular dialysis therapy.
    Lindsay RM; Kennedy AC
    Proc Eur Dial Transplant Assoc; 1972; 9():437-54. PubMed ID: 4668921
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Corral E; Martín A; Solinís MA; Muñoz JL
    Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of complement activation, cytokine liberation and beta 2 microglobulin in the use of various dialysis and hemofiltration membranes].
    Falkenhagen D; Thomaneck U; Brown GS; Werner H; Klinkmann H
    Z Urol Nephrol; 1989 Oct; 82(10):541-50. PubMed ID: 2692346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis membranes for blood purification.
    Sakai K
    Front Med Biol Eng; 2000; 10(2):117-29. PubMed ID: 10898241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [First experiences with the cuprophane coil ExO1].
    Schmidt P; Mayrhofer E; Kotzaurek R
    Wien Med Wochenschr; 1969 May; 119(22):409-11. PubMed ID: 5801628
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodialysis equipment].
    Guey A
    Soins; 2000 Jun; (646):37-8. PubMed ID: 11221354
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of continuous implantable renal replacement: past and future.
    Fissell WH; Fleischman AJ; Humes HD; Roy S
    Transl Res; 2007 Dec; 150(6):327-36. PubMed ID: 18022594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anaphylactoid reactions with the use of ST-AN69 dialysers in patients taking ACE inhibitors].
    Roux VD; Plaisance M
    Nephrol Ther; 2008 Oct; 4(5):335-8. PubMed ID: 18514054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous arteriovenous hemodialysis with cuprophan membrane].
    Cotera A; Lorca E; Saffie A
    Rev Med Chil; 1991 Aug; 119(8):939-40. PubMed ID: 1844779
    [No Abstract]   [Full Text] [Related]  

  • 12. [A method of evaluating the degree of activation of the complement system in patients during hemodialysis].
    Tseitlina EA; Lanskaia IM; Marchenko AL; Rolikhin AE; Sevast'ianov VI
    Med Tekh; 1987; (5):39-43. PubMed ID: 3695894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in hemodialyzers.
    Ronco C; Ballestri M; Brendolan A
    Blood Purif; 2000; 18(4):267-75. PubMed ID: 10965067
    [No Abstract]   [Full Text] [Related]  

  • 14. Dialysis membrane biocompatibility: effects on cellular elements.
    Coli L; De Sanctis LB; Feliciangeli G; Iannelli S; Scolari MP; Todeschini P; Tumietto F; Costigliola P; Chiodo F
    Nephrol Dial Transplant; 1995; 10 Suppl 10():27-32. PubMed ID: 8825429
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of different dialyzer membranes on plasma fibronectin levels in hemodialyzed patients.
    Pertosa G; Pastore A; Schena FP
    Int J Artif Organs; 1989 Jan; 12(1):36-40. PubMed ID: 2925259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ways of intensification of hemodialysis therapy].
    Filiptsev PIa; Kirkhman VV; Timokhov VS
    Ter Arkh; 1988; 60(6):44-7. PubMed ID: 3206368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assessment of dialysis membrane as an endotoxin transfer barrier: geometry, morphology, and permeability.
    Henrie M; Ford C; Andersen M; Stroup E; Diaz-Buxo J; Madsen B; Britt D; Ho CH
    Artif Organs; 2008 Sep; 32(9):701-10. PubMed ID: 18684209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 19. High permeability of dialysis membranes: what is the limit of albumin loss?
    Krieter DH; Canaud B
    Nephrol Dial Transplant; 2003 Apr; 18(4):651-4. PubMed ID: 12637630
    [No Abstract]   [Full Text] [Related]  

  • 20. The polyamide membrane in hemodiafiltration.
    Gonella M; Calabrese G; Pratesi G; Mazzotta A; Vagelli G; Baldin C
    Contrib Nephrol; 1992; 96():99-105. PubMed ID: 1740054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.